
Arven started to develop inhalation products and biologics in 2007. Main goal of the company is to focus on specific product areas and -difficult to make- products. Taking into account the rapidly changing dynamics of global regulatory environment, Toksoz Group decided to start up Arven dedicated only to development and manufacture of inhalation products and biologics. To support this vision, Arven established teams of highly qualified and dedicated research scientists, as well as build a brand new square meter manufacturing facility located in the Kirklareli, Turkey. Arven strives for…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$100M to $250M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.